STOCK TITAN

Canopy Growth to Report Second Quarter Fiscal 2021 Financial Results on November 9, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Canopy Growth Corporation (TSX: WEED, NYSE: CGC) will announce its financial results for the second quarter of fiscal 2021, concluding on September 30, 2020, before markets open on November 9, 2020. Following the results, CEO David Klein and CFO Mike Lee will host an audio webcast at 10:00 AM ET. Canopy Growth continues to lead in the cannabis industry with its diversified product offerings and strong brand presence across Canada, including Tweed and Tokyo Smoke.

Positive
  • Strong brand presence with recognized names such as Tweed and Tokyo Smoke.
  • Diversified product offerings in cannabis, including oils and capsules.
Negative
  • None.

SMITHS FALLS, ON, Nov. 2, 2020 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NYSE: CGC) will release its financial results for the second quarter fiscal 2021 ended September 30, 2020 before financial markets open on November 9, 2020.

Following the release of its second quarter fiscal 2021 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Mike Lee, EVP & CFO at 10:00 AM Eastern Time on November 9, 2020.

Webcast Information
A live audio webcast will be available at:
https://produceredition.webcasts.com/starthere.jsp?ei=1384068&tp_key=9317fbfde9

Replay Information
A replay will be accessible by webcast until 11:59 PM ET on February 7, 2021 at:
https://produceredition.webcasts.com/starthere.jsp?ei=1384068&tp_key=9317fbfde9

About Canopy Growth Corporation
Canopy Growth (TSX:WEED, NYSE:CGC) is a world-leading diversified cannabis, hemp and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth's subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time.

Canopy Growth's medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public's understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.

Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand which has built a large and loyal following by focusing on quality products and meaningful customer relationships.

From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, as well as lifestyle guru Martha Stewart and Fortune 500 alcohol leader Constellation Brands, to name but a few. For more information visit www.canopygrowth.com.

Notice Regarding Forward Looking Statements
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable U.S. and Canadian securities laws (collectively, "forward-looking statements"), which involve certain known and unknown risks and uncertainties. Forward-looking statements predict or describe our future operations, business plans, business and investment strategies and the performance of our investments. These forward-looking statements are generally identified by their use

of such terms and phrases as "intend," "goal," "strategy," "estimate," "expect," "project," "projections," "forecasts," "plans," "seeks," "anticipates," "potential," "proposed," "will," "should," "could," "would," "may," "likely," "designed to," "foreseeable future," "believe," "scheduled" and other similar expressions. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made. Forward–looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those forward–looking statements and the forward–looking statements are not guarantees of future performance. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. A discussion of some of the material factors applicable to Canopy Growth Corporation ("Canopy") can be found under the section entitled "Risk Factors" in Canopy's Annual Report on Form 10-K for the year ended March 31, 2020, filed with the Securities and Exchange Commission and with applicable Canadian securities regulators, as such factors may be further updated from time to time in its periodic filings with the Securities and Exchange Commission and with applicable Canadian securities regulators, which can be accessed at www.sec.gov/edgar and www.sedar.com, respectively. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the filings. Any forward–looking statement included in this press release is made as of the date of this press release and, except as required by law, Canopy disclaims any obligation to update or revise any forward– looking statement. Readers are cautioned not to put undue reliance on any forward–looking statement. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-growth-to-report-second-quarter-fiscal-2021-financial-results-on-november-9-2020-301164284.html

SOURCE Canopy Growth Corporation

FAQ

When will Canopy Growth report its second quarter fiscal 2021 results?

Canopy Growth will report its second quarter fiscal 2021 results on November 9, 2020.

Who will present Canopy Growth's financial results?

CEO David Klein and CFO Mike Lee will present Canopy Growth's financial results.

What time will the Canopy Growth financial results webcast begin?

The webcast will begin at 10:00 AM Eastern Time on November 9, 2020.

What are Canopy Growth’s stock symbols?

Canopy Growth is listed as WEED on the TSX and CGC on the NYSE.

Canopy Growth Corporation Common Shares

NASDAQ:CGC

CGC Rankings

CGC Latest News

CGC Stock Data

341.48M
122.34M
0.18%
8.79%
9.58%
Drug Manufacturers - Specialty & Generic
Medicinal Chemicals & Botanical Products
Link
United States of America
SMITH FALLS